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Abstract 
Ultrasonic vocalizations are widely used to examine affective states in rats, yet rela-
tively few studies explore the acoustic features of vocalizations, especially in relation 
to drug exposure, and no studies have explored alterations in acoustic features over 
time. The goal of this study was to examine nicotine- and phencyclidine-induced al-
terations of bandwidth, duration, and frequency of 50 kHz vocalizations. The min-
imum and maximum frequency, bandwidth, and duration of calls were examined 
after 7 days of daily subcutaneous administration of phencyclidine (2.0 mg/kg) and 
nicotine (0.2 and 0.4 mg/kg) in male Sprague-Dawley rats. Bandwidth was signifi-
cantly decreased in rats treated with both nicotine (0.2 and 0.4 mg/kg) and phen-
cyclidine. Maximum frequency was lowest on the first day of exposure compared 
with all other days and was not altered by drug exposure. Call duration was not af-
fected by time or drug exposure. These findings suggest the importance of studying 
alterations in acoustic features in time, especially those induced by drug exposure. 
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Introduction
Ultrasonic vocalizations (USVs) are widely considered a parameter for 
emotional states in adult rats (Knutson et al., 2002; Brudzynski, 2005, 
2007; Panksepp, 2005; Schwarting et al., 2007) and can be divided into 
two main categories based on a general frequency range: 22 and 50 
kHz. Although 22-kHz USVs are associated with negative or distress-
ing situations (Litvin et al., 2007), 50-kHz USVs are typically emitted in 
response to appetitive contexts and pleasurable stimuli (Knutson et 
al., 1999; Burgdorf et al., 2000; Brudzynski, 2005). USVs in the 50 kHz 
range have also been utilized as a measure of drug reward (Thomp-
son et al., 2006; Ahrens et al., 2009; Mu et al., 2009; Williams and Un-
dieh, 2010). 
Myriad psychoactive drugs with addictive and rewarding proper-
ties have acutely produced alterations in total 50-kHz USVs as well as 
specific subtypes of vocalizations, including amphetamine, cocaine, 
and methylphenidate (Williams and Undieh, 2010; Wright et al., 2010; 
Simola et al., 2012, 2014), whereas other drugs do not produce differ-
ences in total 50 kHz vocalizations. such as morphine, 3,4-methylene-
dioxymethamphetamine, and nicotine (Wright et al., 2010; Sadananda 
et al., 2012; Simola et al., 2010; 2014; Swalve et al., 2016). Vocalization 
patterns are also known to change over time, as seen with amphet-
amine and nicotine (Simola et al., 2014; Swalve et al., 2016). Acous-
tic features of 50 kHz vocalizations such as maximum frequency and 
bandwidth have recently been identified as a method for further ex-
amination of psychoactive substances and may have behavioral sig-
nificance (Brudzynski, 2005; Simola et al., 2012), potentially encod-
ing such information as magnitude or urgency of the signal, but few 
studies have examined these features after drug administration (Si-
mola et al., 2012). Stimulants such as methylphenidate and nicotine 
differentially affect the acoustic features of 50 kHz vocalizations, with 
methylphenidate increasing the maximum frequency and bandwidth, 
whereas nicotine only increased bandwidth, suggesting that class and 
type of stimulant differentially affects acoustic features, yet sensitivity 
of these features to chronic use of drugs is currently unknown. 
This study examined the long-term alterations in acoustic features 
of 50 kHz vocalizations produced by two drugs of abuse, phencycli-
dine (PCP) and nicotine. In a previous study, we found that chronic but 
not acute nicotine increased 50 kHz vocalizations, whereas PCP acutely 
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decreased the total number of vocalizations (Swalve et al., 2016). How-
ever, the long-term effects of nicotine on features such as bandwidth 
and maximum frequency as well as the potential significance of these 
chronic alterations are unknown. We hypothesized that nicotine would 
increase the maximum frequency and bandwidth similar to Simola et 
al. (2012), with frequency increasing over time. However, as the acous-
tic features of vocalizations during PCP exposure have never been ex-
amined, the direction of its effect cannot be predicted. 
Methods
Subjects 
Twenty-four male Sprague-Dawley rats (age 7–9 weeks, 275–299 g 
upon arrival) from Harlan Inc. (Indianapolis, Indiana, USA) were used. 
All rats were single-housed in clear rectangular polycarbonate tubs 
(48.3 cm × 26.7 cm × 20.3 cm) after arrival to avoid isolation-induced 
stress and vocalizations that would occur during the experimental pro-
cedures if rats were pair-housed. This dataset was analyzed for a prior 
experiment (Swalve et al., 2016) but all data reported here are new 
and have never been reported before. Rats had at least 5 days of ha-
bituation to the animal facility with 5 min of handling per day before 
experimental sessions commenced. Experiments were conducted dur-
ing the light portion of a 12-h light/dark cycle (lights on from 6: a.m. 
to 6: p.m.). Housing facilities were maintained at ∼22°C with relative 
humidity of 45–60%. Food and water were both freely available ad li-
bitum throughout all phases of the experiment. All experiments were 
approved by the University of Nebraska–Lincoln Institutional Animal 
Care and Use Committee. 
Apparatus 
Eight identical two-way shuttle boxes, custom designed and manufac-
tured by Med Associates (St Albans, Vermont, USA), housed in venti-
lated, sound-insulated isolation cubicles (96.52 cm width × 35.56 cm 
diameter × 63.5 cm height), were used as chambers. Each shuttle box 
was (64 cm × 30 cm × 24 cm) divided into two equal-sized compart-
ments by a white PVC partition with a doorway (15 cm × 9 cm) with 
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an aluminum hurdle between the two compartments and a grid floor. 
A houselight (50 V) was located at the top of each chamber. All exper-
imental sessions were controlled by Med Associates programs. Back-
ground noise (∼74 dB) and ventilation was provided by a fan affixed 
outside of the chamber in the sound-attenuating cubicle. An USV mi-
crophone (P48 Avisoft Bioacoustics/Emkay Microphone; Avisoft Bio-
acoustics, Berlin, Germany) was mounted on the ceiling of experi-
mental chamber, connected by an E-MU 0404 USB Audio device to 
a computer. Acoustic data were displayed in real time by the Avisoft 
RECORDER, a multichannel triggering hard-disk recording software 
(version 3.4; Avisoft Bioacoustics). Data were recorded at a sampling 
rate of 192 kHz in 16-bit format (version 4.51; Avisoft Bioacoustics). 
Procedure 
Each rat was habituated to the chambers for 30 min per day on 2 con-
current days. Pre-injections of nicotine were given to each rat 2 h af-
ter each habituation day in their home cages to limit the initial aver-
sive effect of nicotine (Bevins and Besheer, 2001). Vocalizations of 
these animals had previously been used to examine the interaction 
of nicotine and PCP on total and categorized vocalizations (Swalve et 
al., 2016). In this experiment, four groups of rats were examined, di-
vided into groups based on drug administration: SAL, SAL–NIC 0.2 
mg/kg (NIC2), SAL–NIC 0.4 mg/kg (NIC4), and PCP. Over 7 total days, 
rats were injected with their corresponding drugs and placed into the 
chambers for 30 min, during which USVs were recorded. 
Spectrograms were generated from the sound files using RavenPro 
1.5 (Cornell Laboratory of Ornithology, Ithaca New York: 512 sample 
Fourier transformation with a Hann window function; filter bandwidth 
135 Hz; frequency resolution 93.8 Hz; grid time resolution 2.13 ms). 
Each spectrogram was visually inspected by two separate trained scor-
ers with an inter-rater reliability of 0.94. The scorers isolated each vo-
calization from the background noise and the acoustic features (min-
imum and maximum frequency, and duration) were calculated using 
the automatic measurement feature in RavenPro. Bandwidth was cal-
culated by taking the maximum frequency and subtracting the mini-
mum frequency for each call. 
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Drugs 
(−) Nicotine tartrate salt (0.2 mg/kg or 0.4 mg/kg; Sigma Aldrich, St 
Louis, Missouri, USA) was dissolved in 0.9% saline to a final pH of 7.0 
± 0.2. Doses are expressed as base. Phencyclidine hydrochloride was 
obtained from the NIDA Chemical Synthesis and Drug Supply Program 
(Bethesda, Maryland, USA) and was mixed with 0.9% saline. All drugs 
were administered subcutaneously before placement in the chamber, 
with PCP administered 10 min and nicotine administered 5 min before 
placement. Two injections were given with at least one injection con-
sisting of saline due to parameters established for Swalve et al. (2016). 
Statistical analyses 
Owing to unequal call numbers elicited by each subject, subjects with 
a minimum of 10 calls each day were selected and the means of each 
acoustic feature were used in all subsequent analyses (see Table 1 
for number of subjects and calls included; see Swalve et al., 2016 for 
analysis of number of calls). Seven rats were excluded due to this cri-
teria (one from NIC2, one from NIC4, three from PCP, and two from 
saline only). Only 50 kHz calls (range: 35–95 kHz) were examined for 
this analysis given the low numbers of 22 kHz calls. Data across 7 days 
from the two nicotine (0.2 and 0.4 mg/kg) administrations were com-
pared with the saline only administration using a mixed-model anal-
ysis of variance (ANOVA; drug × time) for each acoustic feature, fol-
lowed by Fisher’s least significant difference pairwise comparisons. 
Data across the 7 days from the PCP administration were compared 
Table 1. Number of subjects in each condition and the average number of calls re-
corded per day of administration
                                                   Average number of 50 kHz vocalizations
 Number of  
Drug  subjects  Day 1  Day 2  Day 3  Day 4  Day 5  Day 6  Day 7
SAL 6 602.83 272.00 190.17 189.00 189.33 173.00 116.33
NIC2 7 303.71 278.14 211.57 208.86 221.00 242.86 192.57
NIC4 6 218.50 247.67 191.33 226.17 187.17 216.33 172.17
PCP 5 223.80 178.40 242.80 253.00 234.20 223.40 227.20
NIC2, saline–nicotine (0.2 mg/kg); NIC4, saline–nicotine (0.4 mg/kg); PCP, phencyclidine; SAL, 
saline.
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with the saline only condition using mixed-model ANOVAs (drug × 
time) for each acoustic feature, followed by Fisher’s least significant 
difference pairwise comparisons. The criterion for statistical signifi-
cance was P value less than 0.05. 
Results
Nicotine 
For nicotine administration, repeated-measures ANOVAs examining 
the acoustic features (duration, bandwidth, and maximum frequency) 
of the 50 kHz vocalizations found significant effects on the frequency 
measures but no significant effects of drug, time, nor interactions on 
the duration of calls (SAL: M = 0.049, SE = 0.001; NIC2: M = 0.046, 
SE = 0.001; NIC4: M = 0.046, SE = 0.001; NS). There was no signifi-
cant main effect of drug nor interaction between drug and time on 
maximum frequency of 50 kHz calls. There were, however, significant 
changes in the maximum frequency across the 7 days of administra-
tion regardless of drug-type/dose [F(6, 96) = 2.82, P < 0.02, η2 = 0.15] 
with significantly lower maximum frequency for calls emitted on day 
1 compared with subsequent days (P <0.01; Fig. 1). Follow-up re-
peated-measures ANOVAs, examining maximum frequency changes 
in 50 kHz subcategories across time, found that downward ramp, in-
verted-U, step down, and trill calls had significantly lower maximum 
frequency on day 1 (P < 0.05). 
Figure 1. Rat 50 kHz vocalizations had a lower (a) maximum frequency (Hz) on day 
1 of administration (**P<0.01, ***P<0.001) but there were no differences (b) in max-
imum frequency (Hz) between the drug treatments (P>0.05). NIC2, saline–nicotine 
(0.2 mg/kg); NIC4, saline–nicotine (0.4 mg/kg); SAL, saline. 
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A repeated-measures ANOVA found significant changes in the 
bandwidth of the 50 kHz calls during nicotine administration. There 
was a significant main effect of drug [F(2, 16) = 3.83, P < 0.05, η2 = 
0.32; Fig. 2a]. Pairwise comparisons showed that bandwidth was sig-
nificantly smaller for rats administered NIC2 (Hz; M = 12285.62, SE 
= 1018.90, P <0.025) and NIC4 (Hz; M = 12625.85, SE = 1100.54, P 
< 0.05) compared with those administered saline (M = 16110.57, SE 
= 1100.54) but there was no significant difference between the two 
nicotine doses. There was no significant effect of time nor interaction 
between drug and time on the bandwidth of 50 kHz calls, although 
the interaction was trending towards significance (P = 0.052; Fig. 2b). 
Follow-up one-way ANOVAs, examining the subcategories of 50-kHz 
USVs, determined that complex calls decreased in bandwidth follow-
ing low dose nicotine administration (P <0.05), and downward ramp 
and multistep calls had decreased bandwidth after high dose nicotine 
administration compared with saline (P < 0.05; Table 2). 
Phencyclidine 
For PCP administration, repeated-measures ANOVAs examining the 
acoustic features of the 50 kHz vocalizations (duration, bandwidth, 
and maximum frequency) showed that PCP and length of adminis-
tration led to changes in frequency measures (Hz) but there were no 
significant changes in call duration between PCP (M = 0.050, SE = 
0.002) and SAL (M = 0.049, SE = 0.002) administration or across ad-
ministration days. 
Figure 2. Mean bandwidth (Hz) during nicotine administration (a) was smaller in 
both NIC groups compared with saline (*P<0.05) but (b) did not change across the 
7 days of treatment. NIC2, saline–nicotine (0.2 mg/kg); NIC4, saline–nicotine (0.4 
mg/kg); SAL, saline. 
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There was no significant main effect of drug nor interaction be-
tween drug and time on maximum frequency of 50 kHz calls emitted 
by rats. However, there were significant changes in the maximum fre-
quency across the 7 days of administration regardless of drug-type 
[F(6, 54) = 2.67, P<0.05]. Pairwise comparisons revealed that calls 
emitted on day 1 of administration had significantly lower maximum 
frequency than all subsequent days (P<0.05; Fig. 3). Follow-up re-
peated-measures ANOVAs, examining maximum frequency changes 
in 50 kHz subcategories across time, found that flat and step-up 
calls had significantly lower maximum frequency on day 1 (P<0.05). 
Bandwidth, in contrast, was affected by drug administration. Rats 
receiving PCP treatment had significantly smaller bandwidth (Hz; M 
= 12411.18, SE = 1054.37) compared with those administered saline 
(M = 16110.57, SE = 962.50) [F(1, 9) = 6.72, P<0.05; Fig. 4a]. There 
was no significant effect of time on bandwidth, and no significant 
drug x time interaction; though pairwise comparisons between drug-
type on each day of administration, showed that PCP only had signif-
icantly smaller bandwidth on days 1, 4, and 5 (P<0.05; Fig. 4b). Fol-
low-up one-way ANOVAs, examining the subcategories of 50-kHz 
Table 2. Average bandwidth (kHz) and SDs for each 50-kHz ultrasonic vocalization 
subcategory
                                                              Bandwidth [mean (SD)]
Category  SAL  NIC2  NIC4  PCP
Complex  10.93 (1.75)  8.87 (0.69)*  9.09 (2.11)  9.60 (2.04)
Composite  32.68 (3.92)  28.86 (–)  –  28.78 (2.23)
Downward ramp  10.50 (2.99)  7.72 (0.70)  6.93 (1.30)*  5.81 (0.77)*
Flat  2.88 (0.81)  2.60 (0.13)  2.75 (–)  2.37 (0.88)
Flat trill  –  –  –  –
Inverted-U  10.08 (3.90)  9.64 (0.76)  8.29 (0.57)  9.42 (0.51)
Multistep  27.27 (2.56)  23.02 (0.94)  20.56 (4.20)*  29.25 (6.79)
Short  4.85 (–)  3.95 (0.15)  –  3.53 (–)
Split  42.15 (1.89)  39.69 (–)  –  37.46 (–)
Step down  22.58 (4.45)  19.77 (0.02)  –  15.45 (–)
Step up  21.87 (3.65)  21.34 (2.27)  20.46 (2.01)  23.20 (2.92)
Trill  14.00 (3.95)  10.38 (0.75)  11.29 (4.76)  12.81 (3.63)
Trill with jumps  28.91 (3.72)  25.70 (1.38)  26.55 (0.61)  29.17 (3.37)
Upward ramp  9.52 (2.41)  8.75 (1.05)  9.04 (3.18)  8.37 (1.84)
NIC2, saline–nicotine (0.2 mg/kg); NIC4, saline–nicotine (0.4 mg/kg); PCP, phencyclidine; 
SAL, saline.
*P <0.05, significant difference compared with saline administration.
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USVs, determined that only downward ramp calls had significantly 
decreased bandwidth after PCP administration compared with sa-
line (P<0.05; Table 2). 
Discussion 
This study examined the alteration in acoustic features of 50-kHz USVs 
induced by nicotine and PCP exposure. Nicotine did not affect the du-
ration or maximum frequency of calls but decreased bandwidth. PCP 
administration led to changes in frequency measures, including a de-
crease in bandwidth compared with saline. In addition, there was a 
general trend of increasing maximum frequency levels over days for 
Figure 3. Rat 50 kHz vocalizations had a lower (a) maximum frequency (Hz) on day 
1 of administration (*P<0.05, **P<0.01), but there was no difference (b) between 
the PCP and saline treatment groups. PCP, phencyclidine; SAL, saline. 
Figure 4. PCP administration (a) decreased the bandwidth of 50 kHz vocalizations 
compared with saline administration (*P< 0.05) and (b) resulted in change across 
the 7 days of administration. PCP, phencyclidine; SAL, saline. 
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all calls, not dependent on the drug group. This study is the first to 
show that PCP alters the acoustic features of USVs over time. 
Both a low and a high dose of nicotine (0.2 and 0.4 mg/kg) led to 
a decrease in bandwidth but did not alter other features such as call 
duration or maximum frequency. In addition, bandwidth decreases 
in complex, downward ramp, and multistep calls contributed to this 
overall decrease after nicotine administration. This finding is some-
what in opposition to the study of Simola et al. (2012). Although the 
finding that a low dose of nicotine (e.g. 0.2 mg/kg) was not enough 
to evoke differences in frequency measures is similar to that of Simola 
et al. (2012), they found an increase in both maximum frequency and 
bandwidth with the high dose (e.g. 0.4 mg/ kg) and no differences in 
bandwidth of the 50-kHz USV subcategories. 
The lack of modification of maximum frequency and contradictory 
alterations in bandwidth between the current findings and Simola et 
al. (2012) could be explained by methodological differences. In Simola 
et al. (2012), recording sessions lasted 2 h, compared with the 30min 
sessions used here. One potential explanation for this difference is 
that a decrease in the total number of vocalizations due to the short-
ened testing length might have led to low levels of vocalizations, dur-
ing which differences in certain features such as maximum frequency 
could have been masked due to a lack of data points. However, even 
within a shortened session, a minimum of 10 calls were examined, 
with an average of 211 calls, higher than those previously reported in 
Simola et al. (2012), suggesting that such an effect was not likely and 
was not seen in our study. Indeed, other differences in the method-
ology between this work and Simola et al. (2012), such as chamber 
composition, latency to start recording, and total days of acclimation, 
could potentially explain differences between their findings and ours. 
Given the contrast in findings, future research on the short-term and 
long-term effects of nicotine on acoustic features of vocalizations is 
strongly recommended, including an exploration of parametric work 
on the environment most likely to produce vocalization differences. 
Similar to that seen with nicotine, PCP exposure led to smaller 
bandwidth compared with saline groups. Upon further examination 
of subcategories, PCP administration reduced bandwidth in down-
ward ramp calls. The specific modification of bandwidth in compar-
ison to other acoustic features suggests that this feature might re-
late to certain aspects of communication. This literature suggests that 
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vocalizations can be subdivided into 22 and 50 kHz in relation to af-
fective states (Knutson et al., 1999; Burgdorf et al., 2000; Brudzyn-
ski, 2005; Litvin et al., 2007). However, it is possible that alterations of 
bandwidth may also be implicated in affective state. Indeed, band-
width and other acoustic features have been purported to play a sig-
nificant role in communication (Brudzynski, 2005) and may ‘convey 
physiological states’ (Stewart et al., 2015), as decreased bandwidth was 
associated with increased heart rate, which may be related to distress. 
The role of bandwidth in communication is comparatively unknown 
and its relation to the reinforcing value of drugs is unknown. Nico-
tine is purportedly reinforcing and increased bandwidth in Simola et 
al. (2012), along with other drugs that induce rewarding states such 
as morphine and methylphenidate, but decreased bandwidth in this 
study. PCP, in direct contrast, produces a decrease in rewarding states 
(Spielewoy and Markou, 2003) and decreased bandwidth in this study. 
In addition, both D1 and D2 antagonists significantly decrease band-
width (Ringel et al., 2013), and dopamine is linked to many aspects of 
continued drug use including motivation and reward-related stimuli 
(Berridge and Robinson, 1998). Thus, alterations in bandwidth may be 
related to properties of drugs other than reinforcement, which should 
be examined in future studies. 
Neither PCP nor nicotine altered maximum frequency, although rats 
in all groups showed an increase in maximum frequency over days. 
This increase in maximum frequency was primarily driven by low maxi-
mum frequency on the first day of testing in all groups. It may be pos-
sible that experimental parameters could be the cause of low maxi-
mum frequency on the first day, such as the potential stressor of the 
injections; however, animals in the nicotine group had previously un-
dergone injections in their home cage so any alterations in vocaliza-
tions due to injections should have been diminished in at least one 
of the four groups. Although this acoustic feature may not be inte-
gral in examining the effects of drugs, determining how vocalizations 
change over time is important in future research on vocalizations. 
Maximum frequency was altered by nicotine administration in Simola 
et al. (2012) and this particular feature has been suggested to be of 
particular importance in communication (Brudzynski, 2005). Links be-
tween maximum or peak frequency and hedonic aspects of drugs 
have also been hypothesized, as dopamine antagonists differentially 
disrupted this measure (Ringel et al., 2013). Further examination of 
Swalve  et  al .  in  Behav ioural  Pharmacology  30  (2019 )       12
drug-induced alterations of acoustic features over time is warranted, 
as well as elucidation of natural changes in bandwidth and frequency 
and whether these are affected by specific environmental conditions. 
Chronic treatment with both PCP and nicotine significantly de-
creased bandwidth. Maximum frequency was not altered dependent 
on drug exposure but increased over time. These findings suggest that 
acoustic features of natural and drug-induced USVs may change over 
time and future research on USVs as a measure of affective states in 
rats should take this variable into account. 
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